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p47, a p97-binding protein, functions in Golgi membrane fusion together with p97 and VCIP135,
another p97-binding protein. We have succeeded in creating p47 with a point mutation, F253S,
which lacks p97-binding afﬁnity. p47 mapping experiments revealed that p47 had two p97-binding
regions and the F253S mutation occurred in the ﬁrst p97-binding site. p47(F253S) could not form a
complex with p97 and did not caused any cisternal regrowth in an in vitro Golgi reassembly assay. In
addition, mutation corresponding to the p47 F253S mutation in p37 and ufd1 also abolished their
binding ability to p97.
Structured summary:
MINT-7987189, MINT-7987207, MINT-7987303: p47 (uniprotkb:O35987) binds (MI:0407) to p97
(uniprotkb:Q01853) by pull down (MI:0096)
MINT-7987226: p97 (uniprotkb:P46462) binds (MI:0407) to p47 (uniprotkb:O35987) by pull down
(MI:0096)
MINT-7987348: p97 (uniprotkb:P46462) physically interacts (MI:0915) with Ufd1 (uniprotkb:P70362) by
pull down (MI:0096)
MINT-7987264: p97 (uniprotkb:P46462) and p47 (uniprotkb:O35987) bind (MI:0407) by competition
binding (MI:0405)
MINT-7987326: p97 (uniprotkb:P46462) binds (MI:0407) to p37 (uniprotkb:Q0KL01) by pull down
(MI:0096)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The Golgi apparatus plays a central role in intracellular mem-
brane trafﬁc. It undergoes dramatic transformation during the cell
cycle [1]. It is fragmented into thousands of vesicles and short tu-
bules and dispersed throughout the cytoplasm atmitosis [2,3]. Dur-
ing telophase, the mother cell is divided into two daughter cells, in
each of which a Golgi apparatus rapidly reassembles from the frag-
ments [3,4]. Experiments using an in vitro Golgi reassembly assay,
which mimics the reassembly of Golgi stacks at the end of mitosis
[5], showed that reassembly from membrane fragments requires
at least two ATPases; N-ethylmaleimide-sensitive factor (NSF)
and p97 [6]. The role of NSF has been well characterized, while
much less is known about the mechanism of action of p97.chemical Societies. Published by E
ctor; VCIP135, VCP(p97)/p47
e tag; GST, glutathione S-
ndo).p97 has been shown to use two distinct cofactors for its mem-
brane fusion function: p47 is specialized for the reassembly of
organelles at the end ofmitosis; p37 is required for organellesmain-
tenance during interphase as well as for their reassembly during
mitosis [7–9]. p97 also requires a deubiquitinating enzyme,
VCIP135, for itsmembrane fusion function [10]. SinceVCIP135 is an-
other p97-bindingprotein, twop97-binding proteins are involved in
each pathway. It is unclear how p97 utilizes two distinct p97-bind-
ing proteins: p47 and VCIP135 in the p97/p47/VCIP135pathway,
and p37 and VCIP135 in the p97/p37/VCIP135 pathway. While
investigating this point, we have succeeded in isolating a point-mu-
tatedp47which lacks binding afﬁnity to p97. p47has twop97-bind-
ing sites, and the point mutation existed in the ﬁrst binding site.
2. Materials and methods
2.1. Proteins and antibodies
Recombinant p97, p47, p37, Ufd1 and Npl4 were prepared as
reported [7,9,11].lsevier B.V. All rights reserved.
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ing cDNAs with a stop codon were subcloned into pGEX4T-2 (Phar-
macia). These cDNAs were also subcloned into pQE30 (QIAGEN).
Recombinant p47 mutants were expressed in E. coli and puriﬁed
according to manufacturer’s instructions. Eluted samples were fur-
ther puriﬁed using Superose 6 (Pharmacia).
To obtain a peptide, GSVKPKGAFKAKTGEGQKLGSTAPQVLNT
[termed as BSU peptide (a peptide between SEP and UBX do-
mains)], GST-tagged p47(244–270) was prepared in the same
way as the other GST-tagged mutants. After puriﬁcation with glu-
tathione-beads, thrombin was added to the beads to cleave out the
BSU peptide. The eluted BSU peptide was puriﬁed using Superose
12 (Pharmacia).
Point mutations in p47, p37, Ufd1 and BSU peptide were
directly introduced by PCR reactions, using the Quick-changemuta-
genesis kit (Stratagene). All cloneswere veriﬁed byDNAsequencing.
Monoclonal antibodies to p97, GM130 and His-tag were
purchased from Progen, BD Transduction and Qiagen, respectively.
2.2. Isolation of a p47 mutant which lacks binding afﬁnity to p97
p47 mutants were generated and screened as described by
Reddy et al. ([12]). The cDNA of rat p47(170–370) was ampliﬁed
by a PCR reaction in which dATP was limited to 10% of the other
dNTPs in order to generate PCR products with mutations randomly
distributed throughout p47(170–370). The PCR products were sub-
cloned into pGBKT7 vector. The ORF of rat p97 was also subcloned
into pACT2 vector. Both plasmids were co-transformed into yeast
strain AH109 and a yeast two-hybrid screen was carried out essen-
tially according to manufacturer’s protocol.Fig. 1. Two p97-binding sites in p47. (A) Mapping of the p97-binding sites in p47. Each
The beads were incubated with p97 (2 lg) in a buffer containing 0.1% Triton X-100. Aft
antibodies to the His tag on p97. (B) Stripping of p47 from the complex by BSU pepti
incubated with p47 (2 lg). After removing unbound p47, BSU peptide (10 lg) was added
Blots were probed with antibodies to the His tag.2.3. Binding experiments
Binding experiments were performed as described previously
[9]. Brieﬂy, GST-tagged proteins were immobilized to glutathi-
one-beads, and were incubated with other proteins in buffer
(0.15 M KCl, 20 mM HEPES, 1 mM ATP, 1 mM MgCl2, 1 mM DTT,
5% glycerol, 0.1% Triton X-100, pH 7.4). After washing, the proteins
bound on the beads were fractionated by SDS–PAGE and analyzed
by Western blotting.
Golgi membranes were puriﬁed from rat liver ([13])
and washed with 1 M KCl as described previously ([10]). p47
or its mutant was incubated with salt-washed Golgi membranes
in buffer (0.1 M KCl, 20 mM Tris, 0.2 M sucrose, pH 7.4) for 1 h
on ice, and then the membranes were recovered by centrifu-
gation.2.4. ATPase assay
The ATP activity was measured using the technique described in
Tagaya et al. [14]. For this assay, p97 was puriﬁed from rat liver as
described previously [6]. Puriﬁed p97 was pre-incubated with full-
length p47 or its deletion mutants on ice for 30 min before the
assay. Samples were incubated in buffer (0.15 M KCl, 50 mM
Tris–HCl, 2.5 mMMgCl2, 1 mM ATP, 10lCi a-P32 ATP, 15% glycerol,
pH 7.4) for 10–20 min at 37 C. One microliter of the reaction was
then spotted in duplicate on polyethyleneimine cellulose thin layer
plates (Polygram CEL 300PEI) and developed in 0.7 M LiCl, 1 M ace-
tic aid. ATP and ADP spots were quantitated using a phosphorimag-
er (Cyclone, Packard).GST-tagged deletion mutant of p47 (1.5 lg) was immobilized to glutathione-beads.
er washing, the bound p97 was fractionated by SDS-PAGE. Blots were probed with
de. GST-tagged p97 (1.5 lg) that was immobilized to glutathione-beads was ﬁrst
into the beads. After washing, the bound proteins were fractionated by SDS–PAGE.
Fig. 2. Isolation of the p47(F253S) mutant. (A) Amino acid sequence alignment of
p47 homologues (rat p47, human p47, Drosophila EYC and yeast SHP1). Identical
residues between the homologues are marked with asterisks. The arrowhead
indicates Phe-253 in p47. (B) GST-tagged p97 (0.8 lg) was immobilized to
glutathione-beads. The beads were incubated with either His-tagged p47wt or
p47(F253S) (0.05 lg) in a buffer containing 0.15 M KCl and 0.1% Triton X-100 on ice.
The blots were probed with antibodies to p97 and His-tag. (C) Either GST-tagged
p47(244–270) or p47(244–270, F253S) (0.1 lg) was immobilized to glutathione-
beads. The beads were incubated with His-tagged p97 (0.6 lg) on ice. The blots
were probed with antibodies to p97 and GST-tag.
Fig. 3. Complex formation between p97 and p47 is essential for p97/p47/VCIP135-media
p97 (0.5 lg) was pre-incubated with 1 lg of full-length p47 or p47 fragments containing
His-tagged p47wt or p47(F253S) (1.5 lg) was incubated with 1 M KCl-washed Golgi mem
by Western blotting. Blots were probed with antibodies to the His-tag and GM130. (C) M
60 min: p97 (40 lg /ml), p47wt (20 lg /ml), p47(F253S) (20 lg /ml) and BSU peptide (20
0% represents the buffer (22.5% in cisternal membranes) and 100% represents p97/p47w
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The in vitro Golgi reassembly assay was performed as reported
previously [15]. All proteins added in this assay were prepared as
recombinant proteins from E. coli. The length of cisternae was mea-
sured by an intersection method [5].
3. Results and discussion
3.1. Mapping of p97-binding sites in p47
We previously carried out a rough mapping experiments of p47
and showed that p47(171–270) and p47(271–370) fragments inde-
pendently bound to p97 [10]. Bruderer et al. [16] found that the
[246–266] portion of our ﬁrst p97-binding p47 fragment could
bind to p97 in a mapping experiment of ufd1, another p97-binding
protein. Although these rough or fragmented mapping experi-
ments of p47 were reported, comprehensive and detailed p47
mapping data does not exist, and hence we performed such an
experiment as shown in Fig. 1A. p47(171–270) bound to p97 (lane
3) as we previously observed. A C-terminal half fragment (221–
270) and a quarter fragment (244–270), which almost corresponds
to the p97-binding fragment reported by Bruderer et al., bound to
p97 (lanes 6 and 7), but its N-terminal fragment (171–220) could
not bind p97 (lane 5). p47(171–243), which covers the SEP domain,
neither bound to p97 (data not shown). p47(271–370) and its
C-terminal half (311–370), which covers the UBX domain, bound
to p97 (lanes 4 and 9), but its N-terminal half (271–370) did not
(lane 8). Summing up these results, p97-binding regions in p47
were narrowed down to two sites [(244–270) and (311–370)].
The signiﬁcance of the existence of two distinct p97–p47 binding
interactions is thought to increase the conformational diversity
of the complex; it could result in transient or unstable complexes
that use only one p97–p47 binding interaction. Base on this idea,
we previously succeeded in the identiﬁcation of VCIP135, p97/
p47 complex-interacting protein [10].ted Golgi membrane fusion. (A) Inhibition of p97 ATPase by p47 fragments. Puriﬁed
the p97-binding sites. ATPase activities were measured using a-P32 ATP. (B) Either
branes (10 lg) and then the membranes were isolated by centrifugation, followed
itotic Golgi membranes were incubated with the indicated components at 37 C for
lg /ml). Results are presented as the percentage of cisternal regrowth + SD (n = 4):
t (42.7% in cisternal membranes).
Fig. 4. Point-mutated p37 and ufd1. (A) Amino acid sequence alignment of p47, p37
and ufd1. Identical residues between homologues are marked with asterisks. The
arrowhead indicates Phe-253 in p47. (B and C) GST-tagged p97 (0.8 lg) was
immobilized to glutathione-beads. The beads were incubated with the indicated
His-tagged proteins (p37, 0.04 lg; Ufd1, 0.04 lg; Npl4, 0.08 lg) in a buffer
containing 0.15 M KCl and 0.1% Triton X-100 on ice. The blots were probed with
antibodies to p97 and His-tag.
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site actually binds to p97 (Fig. 1B). BSU peptide, which corresponds
to the ﬁrst p97-binding site in p47, stripped p47 from the p97-
beads effectively. Hence, this ﬁrst binding site alone is thought to
have high binding afﬁnity to p97 and to be a good target to produce
a point-mutated p47 lacking p97-binding afﬁnity.
3.2. Isolation of a point-mutated p47 lucking no p97-binding afﬁnity
We next tried to produce p47 mutants which had a point muta-
tion in either the ﬁrst or second p97-binding site. The cDNA of
p47(171–370), containing two p97-binding sites, was ampliﬁed
by a PCR reaction with a limiting amount of dATP, and mutations
were randomly induced in p47(171–370). The resulting p47(171–
370) fragments were expressed in yeast cells and their p97-binding
afﬁnities were tested using a yeast two hybrid system. We
screened 1  103 colonies and successfully obtained three mu-
tants showing low p97-binding afﬁnity; F253S, L339H and L355P.
We then expressed full-length p47 proteins with each mutation
in E. coli. As a result, we found that p47(F253S) became soluble, but
p47(L339H) and p47(L355P) became insoluble. The Phe-253 in p47
is conserved frommammals to yeast (Fig. 2A) and also exists in the
ﬁrst p97-binding site (244–270). Hence, we focused on the F253S
mutant. Fig. 3B shows binding of p47wt and p47(F253S) to GST-
tagged p97. p47wt bound to p97 efﬁciently (lane 1), while
p47(F253S) showed no binding to p97 (lane 2). Since Beuron
et al. predicted nucleotide-dependent conformational changes in
p97 and p47 [17], we tested the effect of nucleotides on the bind-
ing of p47(F253S) to p97 and found that the mutant did not bind to
p97 even in the presence of ATPcS or ADP (data not shown).
We next aimed to clarify that the effect of the F253S mutation
in full-length p47 is mediated by the loss of p97-binding in the ﬁrst
binding site of p47, and hence carried out binding experiments
using GST-tagged p47(244–270) which possessed only the ﬁrst
binding site (Fig. 2C). The F253S-mutated p47(244–270) fragment
never bound to p97 (lane2). Therefore, the F253S mutation abol-
ished the binding ability of the ﬁrst p97-binding site, leading to
lack of binding of full-length p47(F253S) to p97. Phe-253 is in a
highly unstructured region of p47 [18] which could become struc-
tured upon binding to p97. The F253S mutation could alter the nat-
ure of the unstructured linker region, affecting the conformational
changes. Also, the additional negative charges on the Ser could al-
ter the local conformation, masking the interaction site with p97.
3.3. Complex formation between p97 and p47 is essential for p97/p47/
VCIP135-mediated Golgi membrane fusion
In the p97/p47/VCIP135 pathway, p97 has two candidate bind-
ing partners, p47 and VCIP135, and it remains unclear whether
complex formation between p97 and these molecules is really nec-
essary for p97-mediated membrane fusion. Using p47(F253S) and
BSU peptide, we tested this in an in vitro membrane fusion assay.
Fig. 3A shows the effects of p47 fragments on p97 ATPase activ-
ity. p47(171–270) fragment, which containing the ﬁrst p97-bind-
ing site, inhibited p97 ATPase activity, but a smaller fragment
containing the ﬁrst p97-binding site, BSU peptide, did not. This
suggests that BSU peptide is a good tool for inhibiting the binding
of the ﬁrst binding site in p47 to p97, without affecting p97 ATPase
function. Fig. 3B demonstrates that the amount of p47(F253S)
binding to Golgi membranes was almost the same as that of
p47wt, which reveals that the binding ability of p47(F253S) to Gol-
gi membranes is not changed. We also conﬁrmed that the F253S
mutation had no effect on p47 intracellular localization (data not
shown).
Next, the effect of BSU peptide addition and the function of
p47(F253S) in p97-mediated membrane fusion were investigatedusing an in vitro Golgi reassembly assay, as shown in Fig. 3C. The
addition of BSU peptide decreased cisternal regrowth up to 30%
of the positive control. When p47(F253S) was added together with
p97 to mitotic Golgi fragments, no cisternal regrowth was ob-
served. Considering these results, the formation of the p97/p47
complex is thought to be required for p97/p47/VCIP135-mediated
Golgi membrane fusion, and the interaction between p97 and the
ﬁrst binding site in p47 is especially important for the membrane
fusion event.
3.4. Point-mutated p37 and ufd1
As shown in Fig. 4A, sequence alignment of p47, p37 and Ufd1
reveals a short homologous stretch and Phe-253 in p47 is con-
served in p37 and Ufd1. We therefore produced point-mutated
p37 and Ufd1, p37(F215S) and Ufd1(F228S), corresponding to the
F253S mutant of p47. Fig. 4B and C shows their binding to p97.
As expected, neither p37(F215S) nor Ufd1(F228S) bound to p97.
These results also conﬁrm the importance of Phe-253 in p47 for
its binding to p97. p37(F215S) and Ufd1(F228S) are thought to
be dominant negative mutants lacking p97-binding afﬁnity, which
will hence be good tools for the analysis of their function.
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